Huntington’s Disease Clinical Trials Update: September 2024
Farag M. Tabrizi S. Wild E (2024). Huntington’s Disease Clinical Trials Update: September 2024. Journal of Huntington's Disease, 13(4), 409-418. https://doi.org/10.1177/18796397241293955
- Authors
- Mena Farag, Sarah J Tabrizi, Edward J Wild
- Journal
- Journal of Huntington's Disease
- First published
- 2024
- Number of citations
- 5
- Type
- Journal Article
Abstract
In this edition of the Huntington's Disease Clinical Trials Update, we expand on the ongoing extension study of PTC518 from PTC Therapeutics, including 12-month interim results from the parent study. We also discuss 24-month interim results from uniQure's AMT-130 program and 28-week follow-up results from Wave Life Sciences’ SELECT-HD clinical trial of WVE-003. Additionally, we provide a comprehensive listing of all currently registered and ongoing clinical trials in Huntington's disease.